A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Banning, Carina ^a   Votteler, Jörg ^b   Hoffmann, Dirk ^a   Koppensteiner, Herwig ^a   Warmer, Martin ^a   Reimer, Rudolph ^a   Kirchhoff, Frank ^c   Schubert, Ulrich ^b   Hauber, Joachim ^a   Schindler, Michael ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPU PROTEIN; BST2 PROTEIN, HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; HYBRID PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PHOTOPROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SCREENING; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIMIAN IMMUNODEFICIENCY VIRUS; ANIMAL; BINDING SITE; CELL LINE; CONFOCAL MICROSCOPY; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; METABOLISM; METHODOLOGY; MUTATION;

SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIGENS, CD; BINDING SITES; CELL LINE; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE PRODUCTS, NEF; HELA CELLS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; IMMUNOPRECIPITATION; JURKAT CELLS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MUTATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECOMBINANT FUSION PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 77949591605     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009344     Document Type: Article

References (40)

1. Shoemaker BA, Panchenko AR (2007) Deciphering protein-protein interactions. Part I. Experimental techniques and databases. PLoS Comput Biol 3: e42.
2. Piehler J (2005) New methodologies for measuring protein interactions in vivo and in vitro. Curr Opin Struct Biol 15: 4-14.
3. Selvin PR (2000) The renaissance of fluorescence resonance energy transfer. Nat Struct Biol 7: 730-734.
4. Piston DW, Kremers GJ (2007) Fluorescent protein FRET: the good, the bad and the ugly. Trends Biochem Sci 32: 407-414.
5. Yan Y, Marriott G (2003) Analysis of protein interactions using fluorescence technologies. Curr Opin Chem Biol 7: 635-640.
6. Berney C, Danuser G (2003) FRET or no FRET: a quantitative comparison. Biophys J 84: 3992-4010.
7. Hachet-Haas M, Converset N, Marchal O, Matthes H, Gioria S, et al. (2006) FRET and colocalization analyzer-a method to validate measurements of sensitized emission FRET acquired by confocal microscopy and available as an ImageJ Plug-in. Microsc Res Tech 69: 941-956.
8. Ng T, Squire A, Hansra G, Bornancin F, Prevostel C, et al. (1999) Imaging protein kinase Calpha activation in cells. Science 283: 2085-2089.
9. Chan FK, Siegel RM, Zacharias D, Swofford R, Holmes KL, et al. (2001) Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein. Cytometry 44: 361-368.
10. He L, Olson DP, Wu X, Karpova TS, McNally JG, et al. (2003) A flow cytometric method to detect protein-protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP - >YFP fluorescence resonance energy transfer (FRET). Cytometry A 55: 71-85.
11. He L, Grammer AC, Wu X, Lipsky PE (2004) TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. J Biol Chem 279: 55855-55865.
12. Wu X, Currall B, Yamashita T, Parker LL, Hallworth R, et al. (2007) Prestinprestin and prestin-GLUT5 interactions in HEK293T cells. Dev Neurobiol 67: 483-497.
13. You X, Nguyen AW, Jabaiah A, Sheff MA, Thorn KS, et al. (2006) Intracellular protein interaction mapping with FRET hybrids. Proc Natl Acad Sci U S A 103: 18458-18463.
14. Siegel RM, Chan FK, Zacharias DA, Swofford R, Holmes KL, et al. (2000) Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci STKE 2000: PL1.
15. Malim MH, Emerman M (2008) HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398.
16. Thomas SL, Oft M, Jaksche H, Casari G, Heger P, et al. (1998) Functional analysis of the human immunodeficiency virus type 1 Rev protein oligomerization interface. J Virol 72: 2935-2944.
17. Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
18. Schindler M, Wurfl S, Benaroch P, Greenough TC, Daniels R, et al. (2003) Down-modulation of mature major histocompatibility complex class II and upregulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J Virol 77: 10548-10556.
19. Swanson CM, Puffer BA, Ahmad KM, Doms RW, Malim MH (2004) Retroviral mRNA nuclear export elements regulate protein function and virion assembly. EMBO J 23: 2632-2640.
20. Schubert U, Anton LC, Bacik I, Cox JH, Bour S, et al. (1998) CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol 72: 2280-2288.
21. Ptak RG, Fu W, Sanders-Beer BE, Dickerson JE, Pinney JW, et al. (2008) Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses 24: 1497-1502.
22. Kirchhoff F, Schindler M, Specht A, Arhel N, Munch J (2008) Role of Nef in primate lentiviral immunopathogenesis. Cell Mol Life Sci 65: 2621-2636.
23. Nomaguchi M, Fujita M, Adachi A (2008) Role of HIV-1 Vpu protein for virus spread and pathogenesis. Microbes Infect 10: 960-967.
24. Roeth JF, Collins KL (2006) Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev 70: 548-563.
25. Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, et al. (2002) Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol 76: 2692-2702.
26. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, et al. (2006) Nefmediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055-1067.
27. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, et al. (1996) The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 70: 809-819.
28. Moriyoshi K, Richards LJ, Akazawa C, O'Leary DD, Nakanishi S (1996) Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP. Neuron 16: 255-260.
29. Ganesh L, Burstein E, Guha-Niyogi A, Louder MK, Mascola JR, et al. (2003) The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426: 853-857.
30. Xu XN, Laffert B, Screaton GR, Kraft M, Wolf D, et al. (1999) Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 189: 1489-1496.
31. Schaefer TM, Bell I, Pfeifer ME, Ghosh M, Trible RP, et al. (2002) The conserved process of TCR/CD3 complex down-modulation by SIV Nef is mediated by the central core, not endocytic motifs. Virology 302: 106-122.
32. Bour S, Schubert U, Strebel K (1995) The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J Virol 69: 1510-1520.
33. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, et al. (2009) Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 5: e1000450.
34. Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, et al. (2009) Vpu Directs the Degradation of the HIV Restriction Factor BST-2/tetherin via a {beta}TrCP-dependent Mechanism. J Virol.
35. Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, et al. (1994) The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alphahelix-turn-alpha-helix-motif. J Mol Biol 236: 16-25.
36. Dube M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, et al. (2009) Suppression of Tetherin-Restricting Activity on HIV-1 Particle Release Correlates with Localization of Vpu in the trans-Golgi Network. J Virol.
37. Binette J, Cohen EA (2004) Recent advances in the understanding of HIV-1 Vpu accessory protein functions. Curr Drug Targets Immune Endocr Metabol Disord 4: 297-307.
38. Deane CM, Salwinski L, Xenarios I, Eisenberg D (2002) Protein interactions: two methods for assessment of the reliability of high throughput observations. Mol Cell Proteomics 1: 349-356.
39. D'Haeseleer P, Church GM (2004) Estimating and improving protein interaction error rates. Proc IEEE Comput Syst Bioinform Conf. pp 216-223.
40. Huang H, Jedynak BM, Bader JS (2007) Where have all the interactions gone? Estimating the coverage of two-hybrid protein interaction maps. PLoS Comput Biol 3: e214.